Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Invested Capital (2022 - 2026)

Cannabis Bioscience International Holdings filings provide 5 years of Invested Capital readings, the most recent being -$1.5 million for Q1 2026.

  • On a quarterly basis, Invested Capital fell 26.05% to -$1.5 million in Q1 2026 year-over-year; TTM through Feb 2026 was -$1.5 million, a 26.05% decrease, with the full-year FY2025 number at -$1.1 million, down 6.49% from a year prior.
  • Invested Capital reached -$1.5 million in Q1 2026 per CBIH's latest filing, down from -$1.3 million in the prior quarter.
  • The five-year high for Invested Capital was -$405301.0 in Q4 2022, with the low at -$1.5 million in Q1 2026.
  • A 5-year average of -$969755.4 and a median of -$1.1 million in 2024 define the central range for Invested Capital.
  • Year-over-year, Invested Capital tumbled 104.74% in 2023 and then fell 6.49% in 2025.
  • Year by year, Invested Capital stood at -$405301.0 in 2022, then tumbled by 104.74% to -$829807.0 in 2023, then crashed by 35.0% to -$1.1 million in 2024, then dropped by 20.38% to -$1.3 million in 2025, then fell by 7.71% to -$1.5 million in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Invested Capital are -$1.5 million (Q1 2026), -$1.3 million (Q4 2025), and -$1.2 million (Q3 2025).